Piauhy Labs - Medicinal Cannabis

Piauhy Labs is a Portuguese pharmaceutical startup founded in 2018, specializing in medicinal cannabis.

The company focuses on developing EU GMP Pharma-grade personalized cannabinoid medications aimed at treating neurological conditions such as Autism Spectrum Disorder, epilepsy, and Alzheimer’s disease. With a patient-focused and science-based approach, Piauhy Labs aims to create substantial positive changes in patients' lives. Headquartered in Lisbon, Portugal, Piauhy Labs operates a cannabis research center at Biocant Park and is building a Pharma-grade plant in Portugal. The company utilizes advanced technologies like gas chromatography and high-performance liquid chromatography to identify therapeutic compounds. With a small team and private ownership, Piauhy Labs has received early-stage VC investment to support its mission of providing high-quality, personalized phyto-based medicines for individuals suffering from various neurological conditions.